Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key...

3B Future Health Fund announces new investment in iOnctura 3B Future Health Fund announces new investment in iOnctura MONACO, PRINCIPALITY OF MONACO, July 14, 2020:  3B Future Health Fund, previously known as Helsinn Investment Fund S.A., SICAR, today...